CAS 2096989-55-6

Ticagrelor R,R,S,R-Isomer

CAS: 2096989-55-6

Compounds containing a pyrimidine ring, whether or not hydrogenated, or piperazine ring in the structure, nesoi

Fórmula: C₂₃H₂₈F₂N₆O₄S

Cor e Forma: White Off-White Light Yellow Solid

Peso molecular: 522.18608

Ref: 45-1666980

(1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol

CAS: 2096989-55-6

Fórmula: C₂₃H₂₈F₂N₆O₄S

Pureza: 98%

Peso molecular: 522.5680

Ref: IN-DA01D8YQ

(1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol

CAS: 2096989-55-6

(1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol

Pureza: 98%

Ref: 54-PC1001126

ent-Ticagrelor

CAS: 2096989-55-6

Fórmula: C₂₃H₂₈F₂N₆O₄S

Cor e Forma: White To Off-White Solid

Peso molecular: 522.57

Ref: 4Z-T-814

(1R,2R,3S,5R)-3-(7-(((1S,2R)-2-(3,4-difluorophenyl)cyclopropyl)amino)-5-(propylthio)-3H-[1,2,3]triazolo[4,5-d]pyrimidin-3-yl)-5-(2-hydroxyethoxy)cyclopentane-1,2-diol

CAS: 2096989-55-6

Pureza: 98%

Peso molecular: 522.5700073

Ref: 10-F786825

ent-Ticagrelor

Produto Controlado

CAS: 2096989-55-6

Applications ent-Ticagrelor is the enantiomer of Ticagrelor (T437700); the first reversible oral P2Y12 receptor antagonist that provides faster, greater, and more consistent ADP-receptor inhibition than Clopidogrel. Used in the treatment of acute coronary syndromes (ACS).
References Matetzky, S., et al.: Circulation, 109, 3171 (2004); Bassand, J., et al.: Eur. Heart J., 28, 1598 (2007); Jakubowski, J., et al.: Cardiovasc. Drug Rev., 25, 357 (2007)

Fórmula: C₂₃H₂₈F₂N₆O₄S

Cor e Forma: Neat

Peso molecular: 522.57

Ref: TR-T437710

Ent-ticagrelor

CAS: 2096989-55-6

Ent-ticagrelor is a chirally pure pharmaceutical compound, categorized as a P2Y12 receptor antagonist, derived synthetically. This stereoisomer exemplifies the principle of stereochemistry in drug development, focusing on molecular specificity. Its mode of action involves selective binding to the P2Y12 adenosine diphosphate (ADP) receptors on platelets. This binding effectively inhibits the ADP-mediated activation of the GPIIb/IIIa receptor complex, which is crucial for platelet aggregation and clot formation.

Fórmula: C₂₃H₂₈F₂N₆O₄S

Pureza: Min. 95%

Peso molecular: 522.6 g/mol

Ref: 3D-WID98955

Ticagrelor Enantiomer

CAS: 2096989-55-6

Fórmula: C₂₃H₂₈F₂N₆O₄S

Peso molecular: 522.57

Ref: ST-EA-CP-T21107

Ticagrelor Related Compound 34 (DP6)

CAS: 2096989-55-6

Fórmula: C₂₃H₂₆F₂N₆O₅S

Cor e Forma: White To Off-White Solid

Peso molecular: 536.56

Ref: 4Z-T-8149